Restoring digestive motor function to allow better and safer nutrition
Millions of people suffer from reduced or lack of motor function of their digestive system, presented as impaired esophageal motion and delayed gastric emptying, leading to malnutrition and higher risk of infection.
This phenomenon is very common in critically ill patients, as well as neurological, surgical, geriatric, neonatal and others, impairing their general well being and quality of life, while being associated with significant increase in direct medical cost.
E-Motion Medical’s mission is to restore digestive motor function to these patients, reduce infectious complications, and improve survival and physical function.
“Let food be thy medicine
and medicine be thy food”
Our simple, yet revolutionary, technology is designed to shift the paradigm of digestive care, by promoting motor function of the digestive system, improving patient outcomes and lowering the financial burden for healthcare providers.
The E-Motion System™ delivers unique patterns of stimulation to the esophagus, thereby generating contractions, which restore natural function to the digestive system and promote motility throughout the gastrointestinal tract.
The stimulation is applied to the esophagus using our proprietary E-Motion Tube™, which can also double as a feeding tube, and is easily placed in the same manner.
Our technology has been successfully applied to 15 healthy volunteers and more than 120 ICU patients in over a dozen hospitals around the world, in several clinical trials.
The clinical trials demonstrate the safety of our technology, and the effect of the stimulation on gastric emptying, reflux and aspiration, and recuperation time for ICU patients, while minimizing workload for the medical staff.
Investigating physicians who participated in our trials expressed great enthusiasm and some even reported that enrolled patients tended towards faster and better healing than anticipated, as well as fewer complications and infections than can be expected for patients in their condition.
E-Motion Medical Ltd was founded in 2011 by a pioneering multidisciplinary team with extensive experience in medicine, science, management and business.
Chip joined the E-Motion Medical team as President & CEO in March of 2019 after successfully leading his previous organization through an asset transaction with Merit Medical Systems.
A native of the Midwest, Chip has over 18 years of medical device industry experience and has held leadership positions in Training, Strategic Marketing, Global Sales Leadership and Executive Leadership.
Prior to joining E-Motion, Chip was President & CEO for Vascular Insights, a start-up focused on superficial vein disease. Prior to his role at Vascular Insights, Chip held multiple roles of progressive responsibility at Covidien where he drove expansion of the dialysis catheter portfolio’s global footprint. Prior to Covidien, Chip held leadership roles in executive search industry.
Chip holds a bachelor’s degree from Rockhurst University and Master of Business Administration from Baker University and is based in Boston Massachusetts.
Dr. Mascioli is a physician executive with over 25 years of leadership expertise in the medical, clinical and regulatory areas of the medical products industry. He has been successful in establishing the Chief Medical Officer position in 3 companies, demonstrating the ability to form, integrate and manage productive teams across a range of functional areas. His experience includes both pre-market and post-market aspects of product life cycles, and he has worked for start-ups as well as established companies including Boston Scientific, Covidien, Terumo, and American Medical Systems. Dr. Mascioli completed clinical training and gained Board Certification in Internal Medicine. He earned an MD from Boston University, an MPH from the University of Minnesota, and a BA from Brandeis University.
Itzik is a seasoned CFO with more than 20 years of international finance experience and startups know-how. Itzik has successfully managed countless fundraising and M&A and IPO processes of high-tech companies, including: ECtel (NSDQ), Demisto (acquired by Palo Alto Networks), WatchDox (acquired byBlackBerry), KitLocate (acquired by Yandex), and many more.
Itzik has also established Nextage’s US office and is also leading the Tel- Aviv office.
Prior to Nextage, Itzik served as a CFO at Octavian Inc. and as a Financial Director at Business Layers, that went through two successful acquisitions. Formerly, Itzik was an Audit Manager at KPMG Somekh Chaikin, specializing in high-tech companies auditing.
Itzik is Certified Public Accountant (CPA) that holds a BA and MBA in business administration from The College of Management Academic Studies. Itzik majored in Accounting and in Financing.
Dr. Tal is an interventional radiologist with expertise in minimally invasive procedures, serving as Head of Interventional Radiology at Assuta Medical Center and Associate Professor at the Yale University School of Medicine.
After graduating from Hadassah Medical School in Jerusalem, Dr. Tal went on to complete his residence at MCP Hahnemann University in Philadelphia and Yale University, and to receive his MBA from the Yale Business School.
Dr. Tal invented several medical devices that are on the market in the US today, and co-founded several medical device companies, such as Accurate Medical Therapeutics, acquired by Guerbet Group.
Dr. Berra is a specialist in anesthesiology and critical care, and has special interest in respiratory care, transfusion medicine and complications in ICU, which he researched for several years at the National Institute of Health.
Dr. Berra serves as attending physician at the Surgical ICU at Massachusetts General Hospital and as Assistant Professor at the Harvard Medical School.
Dr. Berra received his MD from the University of Milan, and completed his residency and fellowship at Massachusetts General Hospital.
Dr. Sessler is a specialist in pediatric and anesthesia, and currently serves as Professor and Chair of Outcomes Research at the Cleveland Clinic and the Outcomes Research Consortium (www.OR.org), which coordinate more than a hundred simultaneous clinical studies.
Dr. Sessler attended Columbia University, and completed pediatric and anesthesia residencies at UCLA.
Dr. Sessler has published a book and over 600 full papers, have been cited more than 25,000 times, and raised more than $35 million in grant funding.
Having served as Director of FDA’s Office of Device Evaluation and as SVP and Chief Regulatory Officer at Medtronic and CR Bard, Dr. Alpert’s influence on current and future of the US healthcare system is instrumental.
Dr. Alpert is a microbiologist and pediatrician with a specialty in infectious diseases with vast experience in clinical and regulatory affairs.
E-Motion Medical LTD
10 HaNehoshet St.
Tel Aviv 69710